Article
COMPARISON ANTIISCHEMIC AND АНТIHYPERTHENTION ACTIVITY OF BISOPROLOL WITH LERKANIDIPIN AT PATIENTS OF HYPERTENSIVE ILLNESS WITH THE STABLE STENOCARDIA OF PRESSURE
| About the author: | Shorikova D.V., Shorikov E.I., Andrusjak O. V, Bordijan P. I. |
| Heading | CLINICAL MEDICINE |
| Type of article | Научная статья |
| Annotation | In the article the antihypertensive and anti-ischemic effects of lerkanidipine and bisoprolol are investigated in patients with arterial hypertension in combination with the stable stenocardia. Basic indices, which characterize coronary, inotropic and chronotropic reserves of the heart on a background the protractive therapy by these medications are analysed. T he estimation of effects of medication is conducted on average data, and also on the treatment fate – an amount of patients with a positive results. It is set that both medicines have the expressed antihypertensive activity, although lerkanidipine reduces systolic pressure expressed more. In relation to anti-ischemic activity: both drugs – lerkanidipine and bisoprolol – in certain incresed coronary reserve of heart, although on the amount of fate bisoprolol was certain more effective than lerkanidipine. |
| Tags | arterial hypertension, stable stenocardia, veloergometry, lerkanidipine, bisoprolol. |
| Bibliography | 1. Бобилєв О.В. Проби з дозованим фізичним навантаженням в діагностиці серцево-судинних захворювань / О.В.Бобилєв, М.І. Демешко, Р.С. Хмара – Чернівці: 2000.-24 с. 2. Пересмотр Европейских рекомендаций по ведению артериальной гипертензии: документ рабочей группы Европейского общества гипертензии // Артериальная гипертензия. – 2010. - №1. – с. 63-106. 3. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA / О.Ю. Реброва -М.:Медиа-сфера, 2004.–312с. 4. Calcium channel-blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients // J. Hypertens. – 2009. – Vol. 27. – P. 1136-1151. 5. Comparition of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS–III / R. Willenheimer, E. Erdmann, F. Follath [et al.] // Eur. Heart Fail. – 2004. Vol.6, N4. – P.: 493–500. 6. ESC Expert consensus document Expert consensus document on β-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology / Task Force Members: J. Lopez-Sendу, K. Swedberg, J. McMurray [et al.] // Eur. Heart J. – 2004. - Vol.25,№15.-P. 1341-1362. 7. Mancia G. Prevention of risk factors: beta-blockade and hypertention / G. Mancia // Eur. Heart J. Suppl. 2009. – Vol. 11. – P.: A3-A8. |
| Publication of the article | «World of Medicine and Biology» №4(27), 2010 year, 66-68 pages, index UDK 616.127-005.4-06:616 |